TP53 and breast carcinoma: Given that ER+HER2-/luminal tumors and TNBC/basal-like tumors are two major types of breast cancer with different p53 mutation status [12], we next performed the TCGA analyses separately on both ER+HER2-/luminal and TNBC/basal-like tumors.